Astrana Health: Second Quarter 2025 Earnings Supplement
AI Summary
Key Insights
- 📈 Q2 2025 Financial Performance: Reports revenue of $654.8 million and Adjusted EBITDA of $48.1 million.
- 🚀 FY2025 Guidance: Projects total revenue between $3.1 billion and $3.3 billion, with Adjusted EBITDA ranging from $215 million to $225 million.
- 🤝 Strategic Growth: Highlights the acquisition of Prospect, expanding reach to over 1.6 million patients in value-based arrangements.
- 💰 Value-Based Care Model: Shows 78% of revenues from fully capitated arrangements, transitioning towards full-risk contracts.
- 📊 Financial Highlights: Balance sheet indicates cash and investments totaling $342.1 million as of June 30, 2025.
